In the wake of a recent safety scare in a confirmatory trial of its antibody-drug conjugate Zynlonta, ADC Therapeutics is tightening its belt in an effort to get the most out of its cancer med. On ...
Danish biotech Adcendo has accelerated its progression to a clinical-stage biotech by licensing an antibody-drug conjugate (ADC) from China's Multitude Therapeutics with potential in various forms of ...
An antibody-drug conjugate (ADC) that GSK licensed from China's Hansoh Pharma in a $1.7 billion deal last year has been given breakthrough status by the FDA. The coveted designation for GSK5764227 ...
Synaffix’s glycan-based antibody–drug conjugate technology is experiencing strong demand, based on its potential to improve safety and efficacy of cancer therapies without genetic engineering.
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Abstract: In this article, a 6-GHz, 2-bit, fourth-order continuous-time delta–sigma (CT $\Delta \Sigma $ ) analog-to-digital converter (ADC) fabricated in 28-nm CMOS is presented. It achieves −101- ...
Abstract: Successive approximation register (SAR) ADC architectures are popular for achieving high energy efficiency but they suffer from resolution and speed limitations. On the other hand pipeline ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
This price reflects trading activity during the overnight session on the Blue Ocean ATS, available 8 PM to 4 AM ET, Sunday through Thursday, when regular markets are closed.
Welcome to the website of the Office of Professional and Occupational Regulation (OPOR), an agency within the Department of Professional and Financial Regulation (DPFR). We appreciate your visit to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results